Literature DB >> 20415585

Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease.

Graham C Burdge1, Karen A Lillycrop.   

Abstract

There is considerable evidence for induction of differential risk of noncommunicable diseases in humans by variation in the quality of the early life environment. Studies in animal models show that induction and stability of induced changes in the phenotype of the offspring involve altered epigenetic regulation by DNA methylation and covalent modifications of histones. These findings indicate that such epigenetic changes are highly gene specific and function at the level of individual CpG dinucleotides. Interventions using supplementation with folic acid or methyl donors during pregnancy, or folic acid after weaning, alter the phenotype and epigenotype induced by maternal dietary constraint during gestation. This suggests a possible means for reducing risk of induced noncommunicable disease, although the design and conduct of such interventions may require caution. The purpose of this review is to discuss recent advances in understanding the mechanism that underlies the early life origins of disease and to place these studies in a broader life-course context.

Entities:  

Mesh:

Year:  2010        PMID: 20415585     DOI: 10.1146/annurev.nutr.012809.104751

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  120 in total

1.  Progressive, transgenerational changes in offspring phenotype and epigenotype following nutritional transition.

Authors:  Graham C Burdge; Samuel P Hoile; Tobias Uller; Nicola A Thomas; Peter D Gluckman; Mark A Hanson; Karen A Lillycrop
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

Review 2.  Obesogens, stem cells and the developmental programming of obesity.

Authors:  A Janesick; B Blumberg
Journal:  Int J Androl       Date:  2012-02-28

Review 3.  Epigenetic inheritance of disease and disease risk.

Authors:  Johannes Bohacek; Isabelle M Mansuy
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

4.  Developmental programming of obesity and metabolic dysfunction: role of prenatal stress and stress biology.

Authors:  Sonja Entringer; Pathik D Wadhwa
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2013-07-18

Review 5.  Nutritional models of foetal programming and nutrigenomic and epigenomic dysregulations of fatty acid metabolism in the liver and heart.

Authors:  Jean-Louis Guéant; Rania Elakoum; Olivier Ziegler; David Coelho; Eva Feigerlova; Jean-Luc Daval; Rosa-Maria Guéant-Rodriguez
Journal:  Pflugers Arch       Date:  2013-09-03       Impact factor: 3.657

Review 6.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

7.  Placental DNA methylation alterations associated with maternal tobacco smoking at the RUNX3 gene are also associated with gestational age.

Authors:  Jennifer Z J Maccani; Devin C Koestler; Eugene Andrés Houseman; Carmen J Marsit; Karl T Kelsey
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

Review 8.  Developmental and Transmittable Origins of Obesity-Associated Health Disorders.

Authors:  Arin K Oestreich; Kelle H Moley
Journal:  Trends Genet       Date:  2017-04-21       Impact factor: 11.639

9.  Inhibition of proteolysis in histiotrophic nutrition pathways alters DNA methylation and one-carbon metabolism in the organogenesis-stage rat conceptus.

Authors:  Karilyn E Sant; Dana C Dolinoy; Muna S Nahar; Craig Harris
Journal:  J Nutr Biochem       Date:  2013-02-28       Impact factor: 6.048

Review 10.  Diet, nutrition, and cancer: past, present and future.

Authors:  Susan T Mayne; Mary C Playdon; Cheryl L Rock
Journal:  Nat Rev Clin Oncol       Date:  2016-03-08       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.